Edmond De Rothschild Holding S.A. Incyte Corp Transaction History

Edmond De Rothschild Holding S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$63.34 - $74.11 $997,288 - $1.17 Million	-15,745 Reduced 99.75%	40 $3,000
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $357,084 - $436,904	5,200 Added 49.13%	15,785 $1.09 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $804,671 - $1.06 Million	10,585 New	10,585 $860,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.